CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30383% above fair value
$6.03−0.24 (-3.83%)
Close on Nov 13, 2026Market cap $301.78MP/E –Yield –
CapsoVision cash
Cash and short-term investments held at the end of each period.
No cash figures for CapsoVision
CapsoVision has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?